<?xml version="1.0" encoding="UTF-8"?>
<fig id="F1" orientation="portrait" position="float">
 <label>FIG 1</label>
 <caption>
  <p>Schematic to show processing protocol through clinical and research pipelines for influenza diagnosis. (A) Clinical sample collection (orange), clinical diagnostic testing (yellow), sample processing and sequencing using Oxford Nanopore Technologies (blue), and processing of sequence data (purple). (B) Outline of pooled influenza virus-positive samples into an influenza virus-negative background to generate various titers of influenza virus (from 0 to 10
   <sup>6</sup> genome copies/ml), undertaken in triplicate, and spiked with a standard titer of Hazara virus control at 10
   <sup>4</sup> genome copies/ml. FluA, influenza A virus.
  </p>
 </caption>
 <graphic xlink:href="JCM.00963-19-f0001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
